Clinical Trial Update: Toxicity Markers to Trastuzumab-Deruxtecan (T-DXd) In Patients With Advanced Breast Cancer

View source ↗

Summary

A clinical trial update describing planned analysis of toxicity markers for trastuzumab deruxtecan in patients with metastatic breast cancer. The study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Enhertu (trastuzumab deruxtecan)

Snippet

Sponsor: European Institute of Oncology | Conditions: Metastatic Breast Cancer | Status: RECRUITING